Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure

被引:38
作者
Koitabashi, T [1 ]
Inomata, T [1 ]
Niwano, S [1 ]
Nishii, M [1 ]
Takeuchi, I [1 ]
Nakano, H [1 ]
Shinagawa, H [1 ]
Takehana, H [1 ]
Izumi, T [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Internal Med & Cardiol, Sagamihara, Kanagawa 2288555, Japan
关键词
heart failure; paroxysmal atrial fibrillation; prognosis;
D O I
10.1253/circj.69.823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The prognostic significance of atrial fibrillation (AF) in chronic heart failure (CHF) remains poorly understood. Methods and Results Death and rehospitalizaion for CHF exacerbation for 427 consecutive patients hospitalized from 1996 to 2002 were retrospectively analyzed in relation to cardiac rhythm: sinus rhythm (SR; n=239) or AF (n=188). The AF group was classified according to an Intervention (n=57) or Non-Intervention (n=131) group for defibrillating AF. During the follow-up of 34 23 months, there was no significant difference of mortality or morbidity between the SR and AF groups, or between the Intervention and Non-Intervention groups, respectively. However, the Non-Intervention group consisted of 28 patients with paroxysmal AF (PAF), which spontaneously converted to SR during hospitalization, and 103 with chronic AF (CAF). The rehospitalization for CHF exacerbation was significantly higher in PAF than that in CAF and SR (p=0.00005 and 0.002, respectively). Multivariate Cox analysis demonstrated that, PAF, but not CAF, was a predictor of readmission (relative risk 2.30, p=0.004, 95% confidence interval 1.30 to 4.05). Conclusions The present data implied that PAF coincident with cardiac decompensation could be a new predictor of prognosis for CHF. The management strategies of AF in CHF should be discussed according to the phenotype of AF.
引用
收藏
页码:823 / 830
页数:8
相关论文
共 32 条
[1]   Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial [J].
Agner, E ;
Sygehus, H ;
Aguinaga, L ;
Andersen, HB ;
Arnold, JMO ;
Atie, J ;
Bagger, H ;
Battler, E ;
Bellorini, M ;
Berning, J ;
Bernstein, V ;
Bishop, W ;
Boccardo, DA ;
Bonet, J ;
Borggrefe, M ;
Borts, D ;
Bose, S ;
Buxton, A ;
Caeiro, AA ;
Capone, RJ ;
Carlos, J ;
Jorge, M ;
Caspi, A ;
Chandrashekar, Y ;
Connors, S ;
Constance, C ;
Corrado, G ;
Costi, P ;
Coutu, B ;
Davies, T ;
de Paola, AAV ;
Delage, F ;
Demers, C ;
De Roy, L ;
Dion, D ;
Dionne, N ;
Dong, R ;
Dorian, P ;
Dubner, S ;
Egstrup, K ;
Eldar, M ;
Forzami, T ;
Fruergaard, P ;
Gadsboll, N ;
Garand, M ;
Garcia-Palmieri, MR ;
Gardner, MG ;
Gebhardt, V ;
Giannetti, N ;
Giannoccaro, J .
AMERICAN HEART JOURNAL, 2002, 144 (04) :597-607
[2]  
Allessie MA, 2001, CIRCULATION, V103, P769
[3]   Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure - A report from the Italian network on congestive heart failure (in-CHF database) [J].
Baidasseroni, S ;
De Biase, L ;
Fresco, C ;
Marchionni, N ;
Marini, M ;
Masotti, G ;
Orsini, G ;
Porcu, M ;
Pozzar, F ;
Scherillo, M ;
Maggioni, AP .
EUROPEAN HEART JOURNAL, 2002, 23 (21) :1692-1698
[4]   INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].
BENJAMIN, EJ ;
LEVY, D ;
VAZIRI, SM ;
DAGOSTINO, RB ;
BELANGER, AJ ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844
[5]  
CARSON PE, 1993, CIRCULATION, V87, P102
[6]   Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure [J].
Crijns, HJGM ;
Tjeerdsma, G ;
de Kam, PJ ;
Boomsma, F ;
van Gelder, IC ;
van den Berg, MP ;
van Veldhuisen, DJ .
EUROPEAN HEART JOURNAL, 2000, 21 (15) :1238-1245
[7]   Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation - Observations from the Veterans Affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT) [J].
Deedwania, PC ;
Singh, BN ;
Ellenbogen, K ;
Fisher, S ;
Fletcher, R ;
Singh, SN .
CIRCULATION, 1998, 98 (23) :2574-2579
[8]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[9]   COMPARISON OF NEUROENDOCRINE ACTIVATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION WITH AND WITHOUT CONGESTIVE-HEART-FAILURE - A SUBSTUDY OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) [J].
FRANCIS, GS ;
BENEDICT, C ;
JOHNSTONE, DE ;
KIRLIN, PC ;
NICKLAS, J ;
LIANG, CS ;
KUBO, SH ;
RUDINTORETSKY, E ;
YUSUF, S .
CIRCULATION, 1990, 82 (05) :1724-1729
[10]   ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation -: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology [J].
Fuster, V ;
Rydén, LE ;
Asinger, RW ;
Cannom, DS ;
Crijns, HJ ;
Frye, RL ;
Halperin, JL ;
Kay, GN ;
Klein, WW ;
Lévy, S ;
McNamara, RL ;
Prystowsky, EN ;
Wann, LS ;
Wyse, DG .
EUROPEAN HEART JOURNAL, 2001, 22 (20) :1852-1923